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ABSTRACT 
 
Venous thromboembolism represents a possible major complication following primary or 
revision total joint arthroplasty (TJA), especially in the lower extremities. Several international 
guidelines for deep venous thrombosis (DVT) prophylaxis do not recommend a preoperative 
lower limb duplex ultrasound evaluation before total knee or hip arthroplasty. This study aims at 
determining whether a preoperative doppler ultrasonographic screening represents a cost-
effective complication-preventive methodology. A series of 2678 consecutive patients 
undergoing major hip or knee reconstructive procedures received preoperative assessment for 
DVT via bilateral lower limbs color doppler ultrasonography. The study group included 1697 
females (63.3%) and 981 males (36.7%). Assessment included bilateral examination of common 
femoral, superficial femoral, popliteal, anterior tibial and posterior tibial veins. The preoperative 
ultrasound screening highlighted the presence of DVTs in 120 patients (4.5%). Those patients 
were withdrawn from the operative schedule and began DVT treatment with personalized doses 
of LMWH. Patients underwent knee or hip reconstructive procedures once the preoperative 
doppler ultrasonographic evaluation revealed absence of DVT (minimum 3 months; maximum 6 
months). This study discovered a preoperative asymptomatic DVT in a consistent number of 
patients just before undergoing TJA procedures: without screening they were at risk of 
developing possible life-threatening pathologies. Therefore, we consider it prudent to perform a 
preoperative doppler ultrasonographic screening to detect any pre-existing DVTs, especially in 
patients who are considered high risk. 
 
 
Key terms: DVT prophylaxis, ultrasound, TKA, THA, venous thromboembolic disease
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INTRODUCTION 
 
Deep venous thrombosis (DVT) represents the final step of a complex interaction of events 
including the activation of the clotting cascade in conjunction with platelet aggregation. Patients 
undergoing total joint arthroplasty (TJA) are at high risk for developing a postoperative DVT and 
a subsequent pulmonary embolus (PE). If no prophylaxis was been used, DVT prevalence after 
TJA ranged from 32% to 88%. 
1,2,3,4
 Fortunately, the use of pharmacological and/or mechanical 
prophylaxis has reduced the complication rate to 15-30% 5, 6, 7, 8, though not eliminating the risk 
of a life-threatening situation. As a result, the use of venous thromboembolic prophylaxis (most 
commonly pharmacologic prophylaxis) has become the standard of care for patients undergoing 
elective TJA. However, the controversy between the efficacy of DVT prophylaxis and the 
increased risk for bleeding in the postoperative period continues to exist. Parvizi et al.
9
 have 
shown that patients with a wound hematoma or persistent wound drainage are at higher risk for a 
postoperative deep joint infection, a devastating clinical situation. As a direct consequence of the 
concerns for postoperative bleeding risk and potential for infection, orthopedic surgeons may 
prefer a more risk-averse method to prevent thromboembolic phenomena following TJA, 
especially because the rate of symptomatic PE is similar regardless of the chemoprophylaxis 
agent used.
10
 
In our experience, duplex ultrasonography has been shown to be useful in the preoperative and 
postoperative detection of DVT: routine screening may detect a significant percentage of 
asymptomatic DVT, which is not a completely benign finding. 
11 
We also believe that 
surveillance with duplex scanning is also fundamental in determining efficacy and duration of 
DVT therapy.  
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We performed a prospective serial duplex ultrasonography study to determine incidence of 
preoperative DVT and detection and clinical course evaluation of postoperative isolated distal 
DVT in a consecutive group of patients undergoing primary elective TJA. Our hypothesis was 
that performance of a preoperative and postoperative ultrasound evaluation in all patients 
undergoing TJA is necessary to decrease to decrease the incidence of DVT and pulmonary 
embolisms.  
 
MATERIALS AND METHODS 
A prospective study including 2138 hips and 540 knees in 2678 patients undergoing elective TJA 
was conducted at our institute between September 2009 and December 2013. The study group 
included 1697 females (63.3%) and 981 males (46.7%). The Total Hip Arthroplasty (THA) study 
group included 153 revisions (7%), while the Total Knee Arthroplasty (TKA) group 17 revisions 
(3%). All patients gave informed consent. 
Patients with a previous history of DVT, chronic venous insufficiency, varicose veins, renal 
insufficiency, heart failure, or who were taking oral steroidal/hormonal/ anticoagulant drugs for 
any medical condition were all included in the study. 
Preoperative assessment for DVT was done in all patients on both the lower limbs by color 
Doppler ultrasonography using an Esaote MyLab40 device (Genova, Italy). Assessment included 
examination of bilateral common femoral, superficial femoral, popliteal, anterior tibial, and 
posterior tibial veins. Patients were assessed for flow, visualized thrombus, compressibility, and 
augmentation. A diagnosis of DVT was made where there was visualization of thrombosis, 
absence of flow, lack of compressibility or lack of augmentation. Iliac veins were not visualized 
and the deep femoral vein was visualized only at the junction site. Thigh veins were examined 
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with the patient in a supine position, and popliteal and calf veins with the patient sitting. Pulsed-
wave Doppler and color Doppler modalities could be used for anatomic orientation and venous 
examination but not for documentation of the venous findings. Documentation comprised five 
video/digital sequences for each leg of approximately 60 s duration (1, thigh veins; 2, popliteal 
veins; 3, peroneal veins; 4, posterior tibial veins; 5, anterior tibial veins). 
All patients undergoing THA were operated on using the lateral approach: a mini-posterior 
approach12 was used in all primary THA cases (93% of all hip surgeries). All patients undergoing 
TKA received a standard paramedical approach13: a tourniquet was routinely used. Patients were 
daily assessed for any signs of DVT. All patients were given prophylaxis for DVT for 35 days 
postoperatively: a daily single dose low molecular weight heparin (LMWH) medication 
(Nadroparin 0,4 mL) was given to 32% of the patients, while a daily single dose of Fondaparinux 
was given to 78% of the patients. Two hundred and thirty four patients (9%) were preoperatively 
assuming warfarin because of a collateral pathology: patients suspended warfarin 5 days 
preoperatively and substituted it with a personalized dose of LMWH (“bridging 
Anticoagulation”).14 Warfarin was resumed in the early postoperative period (48 -72 hours).  
Nadroparin is a porcine-derived LMWH that binds to antithrombin III (ATIII) and accelerates 
the inactivation of factor II and factor Xa. Nadroparin halts the coagulation pathway by 
inhibiting the activation of thrombin (factor IIa) by factor Xa. The amplification of the fibrin 
clotting cascade is stopped once factors Xa and IIa are inactivated.  
Fondaparinux (Arixtra) is a synthetic pentasaccharide anticoagulant. Apart from the O-methyl 
group at the reducing end of the molecule, the identity and sequence of the five monomeric sugar 
units contained in fondaparinux is identical to a sequence of five monomeric sugar units that can 
be isolated after either chemical or enzymatic cleavage of the polymeric glycosaminoglycan 
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heparin and heparan sulfate (HS). This monomeric sequence in heparin and HS is thought to 
form the high affinity binding site for the natural anti-coagulant factor, antithrombin III (ATIII). 
Binding of heparin/HS to ATIII has been shown to increase the anti-coagulant activity of 
antithrombin III 1000-fold. Fondaparinux potentiates the neutralizing action of ATIII on 
activated Factor X 300-fold. 
All patients used an intermittent pneumatic boot compression device in the first 24 hours 
postoperatively, while being monitored in a sub-intensive care unit and then during the hospital 
stay in all non-deambulatory situations. As in the preoperative period, assessment for 
postoperative DVT was done by color Doppler ultrasonography on postoperative day 4. The 
same angiologist, who was very experienced in color Doppler ultrasonography, repeated the 
study in all cases. All patients wore below-knee elastic compression stockings for 35 days 
postoperatively. Statistical analysis was performed using Student’s t-test. 
 
RESULTS 
PREOPERATIVE PERIOD 
The preoperative ultrasound screening highlighted the presence of DVTs in 120 patients (4.5%). 
Those patients were withdrawn from the operative schedule and began DVT treatment with 
personalized doses of LMWH. Those patients underwent TJA once the preoperative color 
Doppler ultrasonography revealed absence of DVT (minimum 3 months; maximum 6 months). 
POSTO PERATIVE PERIOD  
The incidence (Table 1) of proximal or distal DVT in patients following total knee arthroplasty 
was found to be 4.8% (26 patients). The incidence of proximal or distal DVT in patients 
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following total hip arthroplasty was 3.2% (69 patients). THA procedure showed more distal 
DVT (62 patients = 2.9%) than proximal DVT (7 patients = 0.3%). TKA procedure showed more 
distal DVT (21 patients = 3.9%) than proximal DVT (5 patients = 0.9%).   No patients developed 
DVT in the contralateral limb. 
 
The difference of overall DVT between groups was not statistically significant (p=0.35). The 
difference of isolated distal DVT between the groups also was not statistically significant 
(p=0.71). All DVTs were asymptomatic clinically.  
All patients began DVT treatment with personalized doses of LMWH or Fondaparinux according 
to the American College of Chest Physicians (ACCP) Evidence-Based Clinical Practice 
Guidelines. 8 None of the patients had a PE in the postoperative period. Patients with acute DVT 
did not receive a period of bed rest but walked as soon as possible to reduce the risk of post-
thrombotic syndrome. All DVT patients wore below-knee elastic compression stockings until 
DVT resolution, as shown by final color Doppler ultrasound. All DVT patients had color 
Doppler ultrasonography for DVT evolution assessment on postoperative day 30, 60, 90 and 120 
if needed.  
 
DISCUSSION 
The presence of DVT in the lower extremities following TJA is generally considered a 
potentially life threatening situation.
15
 Prevention of DVT using duplex ultrasonography to avoid 
the complication of pulmonary embolism is effective.
16
 The fundamental aid from preoperative 
color Doppler evaluation is to identify the location of a silent DVT. In fact,  
proximal DVTs are well known to be closely associated with increased risk of pulmonary 
embolism and are conventionally treated more aggressively with closer monitoring. 
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On the other hand, the role of distal DVT is less obvious. Although once thought to be quite 
benign 
17
, distal DVT also has been reported to be associated with pulmonary embolism, 
especially when a distal DVT is propagated to a more proximal location
18 
:  recently Grady-
Benson et al.
14
 used serial venous Dopper flow measurements to document a propagation rate of 
24% in the calf. DVT formation during TJA could be related to the flexion posture of the lower 
limb during the procedure or the use of a tourniquet on the thigh causing stasis or surgical trauma 
to the surrounding vasculature during the release. 
Unfortunately, Duplex ultrasonography as a non-invasive screening tool has not yet received 
universal acceptance
17
 despite promising reports.
18 
In fact, Ko et al.
 18
 showed that preoperative 
Doppler ultrasonography prevents any false positive cases and forewarns the surgeon regarding 
the increased risk of DVT and need for prophylaxis. The preoperative ultrasound screening 
demonstrated a DVT in 4.5% of our patients: without screening they were at risk of developing a 
perioperative pulmonary embolism. Therefore, the authors of the current study believe it is 
prudent to do preoperative Doppler ultrasonography to detect any pre-existing DVT, especially 
in patients who are considered at high risk as shown in Table 2 (old age, BMI>30, history of 
venous thromboembolism, revision joint surgery, congestive heart failure, chronic rheumatic 
heart disease, steroid/hormonal/anticoagulant therapy, varicose veins, prolonged immobilization, 
malignancy, factor V Leiden, etc.). In fact, preoperative and postoperative clinical findings alone 
are generally considered poor predictors of the presence of DVT.
19 
Once a DVT episode has 
been detected, surveillance with duplex scanning also is mandatory in determining efficacy and 
duration of therapeutic anticoagulation for DVT.
20,21
 
Our study does not specifically address the issue of indication and timing of initiation of 
anticoagulation therapy for patients undergoing TJA. Although the value of routine 
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pharmacologic thromboprophylaxis in TJA has been questioned by metanalysis22, the majority of 
surgeons would still recommend some form of prophylaxis against DVT
7
 in view of the 
morbidity and mortality associated with postoperative DVT in THA and TKA. The authors of 
the current study recognize that venous thromboembolic events following primary hip and knee 
arthroplasty have decreased significantly over the past two decades mainly due to a 
multidisciplinary approach. Rapid postoperative mobilization, optimization of surgical 
technique, and improved perioperative pain management (including the use of regional 
anesthesia)  have all contributed to decreasing the DVT risk. At the author’s institution, we use  
pharmacolocic and mechanical approaches for thromboprophylaxis after TJA as suggested by the 
2012 American College of Chest Physicians (ACCP) Evidence-Based Clinical Practice 
Guidelines
12
 and the 2009 Tuscany Region Protocol for Thromboprophylaxis in Orthopaedic 
Surgery (www.regione.toscana.it). All patients undergoing a TJA procedure receive a form of 
pharmacologic thromboprophylaxis (low-molecular-weight heparin or fondaparinux) for 35 days 
postoperatively, use an intermittent pneumatic compression device during the hospital stay, and 
wear below knee elastic compression stockings for 35 days postoperatively. The main difference 
from 2012 ACCP guidelines12 was that all our patients underwent Doppler ultrasonography 
screening preoperatively and postoperatively before hospital discharge. Doppler ultrasonography 
is historically a non-invasive procedure and provides good sensitivity (89%) and specificity 
(100%) for detecting DVT.
4 
There is a lack in the literature on the appropriateness of 
preoperative Doppler ultrasonography in patients undergoing TJA: Sisodia et al.
23 
recently 
reported 22.4% preoperative asymptomatic DVTs in a group of patients awaiting TJA. The 
current study supports the benefit of Doppler ultrasonography as a preoperative and 
postoperative investigation method in patients undergoing TJA.  
 
Page 10 of 15 
PE
ER
 RE
VIE
W 
CO
PY
 
 
 
 
 
 
 
 
 
ED
IZI
ON
I M
INE
RV
A M
ED
ICA
International Angiology
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
10 
 
 
 
REFERENCES 
 
1. Brookenthal KR, Freedman KB, Lotke PA et al (2001) A meta-analysis of 
thromboembolic prophylaxis in total knee arthroplasty. J Arthroplasty 16:293–300 
 
2. Clagett GP, Anderson FA, Heit J et al (1995) Prevention of venous 
thromboembolism. Chest 108:312S–334S 
 
3. Clarke MT, Green JS, Harper WM et al (1997) Screening for deep vein thrombosis 
after total hip and knee replacement without prophylaxis. J Bone Joint Surg [Br] 
79:787–791 
 
4. Cronan JJ, Dorfman GS, Scola FH et al. (1987) Deep venous thrombosis: US 
assessment using vein compression. Radiology 162:191–4. 
 
5. Davidson BL, Elliott CG, Lensing AW. (1992) Low accuracy of color Doppler 
ultrasound in the detection of proximal leg vein thrombosis in asymptomatic high-
risk patients. The RD Heparin Arthroplasty Group. Ann Intem Med 1992;117:735–
8. 
 
6. Doouss TW (1976) The clinical significance of venous thrombosis of the calf. 
British J Surg 63:377–378 
 
7. Francis CW, Pellegrini VD Jr, Totterman S et al (1997) Prevention of deep-vein 
thrombosis. J Bone Joint Surg [Am] 9:1365–1372 
 
 
8. Gordon H. Guyatt, Elie A., Mark Crowther et al. (2012)  Antithrombotic Therapy 
and Prevention of Thrombosis, 9th ed:  American College of Chest Physicians 
Evidence-Based Clinical Practice Guidelines  Chest. 2012;141(2_suppl):1S. 
doi:10.1378/chest.1412S1 
 
9. Grady-Benson JC, Oishi CS, Hanson PB et al (1994) Postoperative surveillance 
for deep vein thrombosis with duplex ultrasonography after total knee arthroplasty. 
J Bone Joint Surg [Am] 11:1649–1657 
 
 
10. Ko P.S., Chan W.F., Siu T.H. et al. (2003) Duplex ultrasonography after total hip 
or knee arthroplasty. International Orthopaedics (SICOT) 27:168–171 
 
Page 11 of 15 
PE
ER
 RE
VIE
W 
CO
PY
 
 
 
 
 
 
 
 
 
ED
IZI
ON
I M
INE
RV
A M
ED
ICA
International Angiology
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
11 
 
11. Lieberman JR, Pellegrini VD. (1999) Orthopaedic knowledge update 6. Rosemont: 
American Academy of Orthopaedic Surgeon. 
 
 
12. Marcucci M, Indelli PF, Latella L, Poli P, King D: “A multimodal approach in 
total hip arthroplasty preoperative templating”. Skeletal Radiology (2013) 42 (9): 
pp 1287-1294. 
13. Indelli PF, Marcucci M, Pipino G, Charlton S, Carulli C, Innocenti M. “The effects 
of femoral component design on the patello-femoral joint in a PS total knee 
arthroplasty”. Arch Orthop Trauma Surg. 2014 Jan; 134 (1):59-64. 
 
14. Lohr JM, James KV, Deshmukh RM et al (1995) Calf vein thrombi are not a 
benign finding. Am J Surg 170:86–90 
 
15. Lotke PA, Steinbery ME, Ecker ML (1994) Significance of deep vein thrombosis 
in the lower extremity after total joint arthroplasty. Clin Orthop 299:25–30 
 
16. Masuda EM, Kessler DM, Kistner RL et al. (1998 )The natural history of calf vein 
thrombosis: lysis of thrombi and development of reflux. J Vasc Surg.28(1):67-73; 
discussion 73-4. 
 
17.  McKenna R, Bachmann F, Kaushal SP et al (1976) Thromboembolic disease in 
patients undergoing total knee replacement. J Bone Joint Surg [Am] 58:928–932 
                     
18. Murray DW, Britton AR, Bulstrode CJ (1996) Thromboprophylaxis and death 
after total hip replacement. J Bone Joint Surg [Br] 78:863–870 
 
19.  National Institutes of Health Consensus Development Conference statement 
(1986) Prevention of venous and pulmonary thromboembolism. JAMA 256:744–
749 
 
20.  Parvizi J, Ghanem E, Joshi A et al. (2007) Does ‘‘excessive’’ anticoagulation 
predispose to periprosthetic infection? J Arthroplasty  22(6 Suppl 2):24–8. 
 
21.  Planes A, Samama MM, Lensing AW et al (1999) Prevention of deep vein 
thrombosis after hip replacement. Thromb Haemost 81:22–25 
 
Page 12 of 15 
PE
ER
 RE
VIE
W 
CO
PY
 
 
 
 
 
 
 
 
 
ED
IZI
ON
I M
INE
RV
A M
ED
ICA
International Angiology
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
12 
 
 
22. Stulberg BN, Insall JN, Williams GW et al (1984) Deep vein thrombosis following 
total knee replacement. An analysis of six hundred and thirty-eight arthroplasties. J 
Bone Joint Surg [Am] 66:194–201 
 
23.  Sisodia G, Garnet Fernando WS, Melton C, et al.(2013):  The incidence of pre-
operative asymptomatic DVT among patients awaiting total knee arthroplasty or 
total hip arthroplasty. 
http://www.nlg.nhs.uk/services/radiology/The.incidence.of.preop.DVT.in.patients.
awaiting.TKR.and.THR.pdf .    Accessed 12/22/13 
 
24.  Westrich GH, Haas SB, Mosca P et al. (2000) Meta-analysis of thromboembolic 
prophylaxis after total knee arthroplasty.. J Bone Joint Surg Br. 82(6):795-800. 
 
 
 
 
 
Page 13 of 15 
PE
ER
 RE
VIE
W 
CO
PY
 
 
 
 
 
 
 
 
 
ED
IZI
ON
I M
INE
RV
A M
ED
ICA
International Angiology
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
1) Table 1:  
 
Incidence and location of ultrasonographically confirmed postoperative deep vein thrombosis 
(DVT). TKA total knee arthroplasty; THA total hip arthroplasty 
 
 
Arthroplasty 
Type 
No. Patients Proximal DVT Distal DVT Total DVT 
TKA 540 5 (0.9%)  21 (3.9%) 26 (4.8 %) 
THA 2138 7 (0.3%) 62 (2.9 %) 69 (3.2 %) 
Total 2678    
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2) Table 2 
High risks factors for deep vein thrombosis (DVT) 
• Old age 
• BMI>30  
• History of venous thromboembolism   
• Revision joint surgery  
• Congestive heart failure  
• Chronic rheumatic heart disease  
• Steroid/hormonal therapy 
• Anticoagulant therapy  
• Varicose veins  
• Prolonged immobilization  
• Malignancy  
• Factor V Leiden 
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